Drug
remifentanil group
remifentanil group is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_3
1
20%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Opioid Sparing General Venous Anesthesia With Magnesium Sulfate
NCT04005599
completedphase_3
Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant
NCT03960801
terminatednot_applicable
Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures
NCT03451227
completednot_applicable
Emergence Agitation in Pediatric Strabismus Surgery
NCT03807011
completedphase_4
Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation
NCT01474213
Clinical Trials (5)
Showing 5 of 5 trials
NCT04005599Not Applicable
Opioid Sparing General Venous Anesthesia With Magnesium Sulfate
NCT03960801Phase 3
Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant
NCT03451227Not Applicable
Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures
NCT03807011Not Applicable
Emergence Agitation in Pediatric Strabismus Surgery
NCT01474213Phase 4
Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5